In a comprehensive study Kate Sutherland et al. evaluated promoter CpG island methylation and loss of heterozygosity (LOH) of the SOCS1, SOCS2 and SOCS3 genes in ovarian and breast cancer [8]. This evidence concerns the gene SOCS1 and breast cancer.